GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Cyclically Adjusted PS Ratio

Surgical Innovations Group (LSE:SUN) Cyclically Adjusted PS Ratio : 0.55 (As of Dec. 13, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Cyclically Adjusted PS Ratio?

As of today (2024-12-13), Surgical Innovations Group's current share price is £0.0055. Surgical Innovations Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was £0.01. Surgical Innovations Group's Cyclically Adjusted PS Ratio for today is 0.55.

The historical rank and industry rank for Surgical Innovations Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

LSE:SUN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.41   Med: 1.48   Max: 3.45
Current: 0.41

During the past 13 years, Surgical Innovations Group's highest Cyclically Adjusted PS Ratio was 3.45. The lowest was 0.41. And the median was 1.48.

LSE:SUN's Cyclically Adjusted PS Ratio is ranked better than
88.1% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 2.37 vs LSE:SUN: 0.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Surgical Innovations Group's adjusted revenue per share data of for the fiscal year that ended in Dec23 was £0.013. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is £0.01 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surgical Innovations Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Surgical Innovations Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Cyclically Adjusted PS Ratio Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.15 1.71 1.15 0.45

Surgical Innovations Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.15 - 0.45 -

Competitive Comparison of Surgical Innovations Group's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Surgical Innovations Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Cyclically Adjusted PS Ratio falls into.



Surgical Innovations Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Surgical Innovations Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0055/0.01
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Innovations Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Surgical Innovations Group's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.013/130.5000*130.5000
=0.013

Current CPI (Dec23) = 130.5000.

Surgical Innovations Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.009 99.900 0.012
201512 0.011 100.400 0.014
201612 0.012 102.200 0.015
201712 0.013 105.000 0.016
201812 0.013 107.100 0.016
201912 0.012 108.500 0.014
202012 0.008 109.400 0.010
202112 0.010 114.700 0.011
202212 0.012 125.300 0.012
202312 0.013 130.500 0.013

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surgical Innovations Group  (LSE:SUN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Surgical Innovations Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.